M, v. G., A, v. K., S, S., M, E., M, v. E., J, M., . . . T, v. H. (2023). PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance. Science immunology, 8(83), eabn6173. https://doi.org/10.1126/sciimmunol.abn6173
Chicago Style (17th ed.) CitationM, van Gulijk, et al. "PD-L1 Checkpoint Blockade Promotes Regulatory T Cell Activity That Underlies Therapy Resistance." Science Immunology 8, no. 83 (2023): eabn6173. https://doi.org/10.1126/sciimmunol.abn6173.
MLA (9th ed.) CitationM, van Gulijk, et al. "PD-L1 Checkpoint Blockade Promotes Regulatory T Cell Activity That Underlies Therapy Resistance." Science Immunology, vol. 8, no. 83, 2023, p. eabn6173, https://doi.org/10.1126/sciimmunol.abn6173.
Warning: These citations may not always be 100% accurate.